Secure-IC's Securyzr™ Tunable Hash (SM3) Hardware accelerator
Japan set to save Renesas
Peter Clarke, EETimes
10/15/2012 4:50 AM EDT
LONDON – Struggling Japanese chip company Renesas Electronics Corp. now looks set to be saved by a Japanese buy-out led by a government investment fund.
The fund called the Innovation Network Corp. of Japan (INCJ) plans to invest 150 billion yen (about $1.9 billion) in Renesas in return for a two-thirds stake in the company. A group of about 10 companies will invest a further 50 billion yen in total, according to reports that referenced a Nikkei and Daily Yomiuri newspaper reports.
The INCJ is expected to appoint senior manager from outside the company and to sell off the System LSI business unit for integration with similar units at Fujitsu and Panasonic, according to a Daily Yomiuri report.
|
|
E-mail This Article |
|
Printer-Friendly Page |
|
||||||
Related News
- Renesas to Cut 1,000 Jobs in Japan
- Renesas Demonstrates Deterministic Deep Database Search Engine Interoperating with Xilinx’s FPGA-Based Packet Processor at Japan IT Week 2015
- NXP + Freescale Merger Set To Create Leading Vendor of Automotive Semiconductors in 2015; Renesas Was The Largest Vendor in 2014
- Yoshida in Japan: Renesas' cuts are GloFo's gain
- Renesas shareholders reportedly set to approve bailout deal
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






